ArticleAbdominal radiology (New York)2026
Four-dimensional flow MRI-based prediction of minimal hepatic encephalopathy in patients with liver cirrhosis.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectivesTo develop a noninvasive predictive model for minimal hepatic encephalopathy (MHE) according to the blood flow indices of spontaneous portosystemic shunt (SPSS) on four-dimensional (4D) flow MRI in patients with liver cirrhosis.
methodsA consecutive cohort of patients with liver cirrhosis complicated with enhanced abdominal CT-confirmed SPSS from April 2022 to October 2023 was prospectively recruited and divided into MHE and non-MHE groups. All patients underwent portal vascular imaging with 4D flow MRI, the blood flow indices of SPSSs (mainly including gastroesophageal shunts (F-GES) and splenorenal/gastrorenal shunts (F-SRS/F-GRS)), the splenic vein (F-SV), and the superior mesenteric vein (F-SMV) were measured. Additionally, the total crosssectional area of the SPSSs (TA-S) on enhanced CT, demographic characteristics and clinical factors were collected. Clinical, morphological, hemodynamic, and combined predictive models (Model
resultsA total of 72 patients (mean age 53.9 ± 8.0 years, 43 males) were included, with 27 in the MHE group and 45 in the non-MHE group. Child-Pugh class C, TA-S, F-GES, F-SRS/F-GRS and F-SV were factors influencing the presence of MHE. The combined Model
conclusion4D flow MRI can reveal the hemodynamic characteristics of SPSSs in patients with liver cirrhosis, and a prediction model based on its hemodynamic index and clinical factors can provide valuable insights for early detection and serving as a clinical foundation for timely intervention in MHE.
Indexed as
Identifiers
42089989What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.